Western Development Commission

Type

Venture Capital

Status

Active

Location

Ballaghadereen, United Kingdom

Total investments

39

Average round size

3M

Portfolio companies

32

Rounds per year

1.50

Lead investments

3

Follow on index

0.18

Exits

4

Stages of investment
SeedEarly Stage Venture
Areas of investment
Therapeutic DevicesBiotechnologySoftwareRetailInformation TechnologyArtificial IntelligenceHealth CareEnterprise SoftwareMedical DeviceMedical

Summary

Western Development Commission is the famous Corporate Investor, which was founded in 1998. The leading representative office of defined Corporate Investor is situated in the Ballaghaderreen. The venture was found in Europe in Ireland.

The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The increased amount of exits for fund were in 2017. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. This Western Development Commission works on 8 percentage points less the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this Corporate Investor is 13 percentage points less often commits exit comparing to other organizations.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Western Development Commission, startups are often financed by ic@3401, Fountain Healthcare Partners, Enterprise Ireland. The meaningful sponsors for the fund in investment in the same round are Enterprise Ireland, Enterprise Equity, Fountain Healthcare Partners. In the next rounds fund is usually obtained by IPF Partners, European Innovation Council, European Commission.

The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - Ireland. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical, Health Care. Among the most popular portfolio startups of the fund, we may highlight Embo Medical, Kelsius, Bluedrop Medical.

Show more

Investor highlights

Industry generalist
Yes
Industry focus
GeneralistClimate techFoodtechManufacturingCommunity/Social network Show 7 more
Stage focus
GeneralistSeedSeries DSeries CSeries A Show 3 more
Geo focus
Check size
54K — 1M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Last fund

Fund size
EUR 75000000
Fund raised date
2022-06-22

Analytics

Total investments
39
Lead investments
3
Exits
4
Rounds per year
1.50
Follow on index
0.18
Investments by industry
  • Medical Device (17)
  • Health Care (17)
  • Biotechnology (10)
  • Medical (8)
  • Information Technology (5)
  • Show 45 more
Investments by region
  • Ireland (37)
  • United States (2)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
9
Avg. valuation at time of investment
893K
Group Appearance index
0.95
Avg. company exit year
5

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Neuravi 17 Jun 2015 Health Care, Collaboration, Medical Device Early Stage Venture 22M Galway, Galway, Ireland
Peroptyx 10 Jul 2024 Information Technology, Artificial Intelligence, Machine Learning Seed 1M Ireland, County Mayo, Ireland

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.